JP2025016453A5 - - Google Patents

Download PDF

Info

Publication number
JP2025016453A5
JP2025016453A5 JP2024169863A JP2024169863A JP2025016453A5 JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5 JP 2024169863 A JP2024169863 A JP 2024169863A JP 2024169863 A JP2024169863 A JP 2024169863A JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5
Authority
JP
Japan
Prior art keywords
collagenase
formulation
μbar
lyophilized
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024169863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025016453A (ja
JP7855655B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2020/012202 external-priority patent/WO2020142701A1/en
Application filed filed Critical
Publication of JP2025016453A publication Critical patent/JP2025016453A/ja
Publication of JP2025016453A5 publication Critical patent/JP2025016453A5/ja
Application granted granted Critical
Publication of JP7855655B2 publication Critical patent/JP7855655B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024169863A 2019-01-06 2024-09-30 コラゲナーゼ製剤およびその製造方法 Active JP7855655B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962788916P 2019-01-06 2019-01-06
US62/788,916 2019-01-06
PCT/US2020/012202 WO2020142701A1 (en) 2019-01-06 2020-01-03 Collagenase formulations and methods of producing the same
JP2021539410A JP7565280B2 (ja) 2019-01-06 2020-01-03 コラゲナーゼ製剤およびその製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021539410A Division JP7565280B2 (ja) 2019-01-06 2020-01-03 コラゲナーゼ製剤およびその製造方法

Publications (3)

Publication Number Publication Date
JP2025016453A JP2025016453A (ja) 2025-02-04
JP2025016453A5 true JP2025016453A5 (enExample) 2025-04-25
JP7855655B2 JP7855655B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
Thakral et al. Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations
AU2018203556B2 (en) Recombinant clostridium botulinum neurotoxins
Toyoda et al. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus
KR101744900B1 (ko) 보툴리눔 독소를 포함하는 안정한 액상 조성물
EP2652131B1 (de) Lagerstabiles flüssiges wasch- oder reinigungsmittel enthaltend protease und amylase
CN102202688B (zh) 稳定、干燥的轮状病毒疫苗、其组合物和制备其的方法
JP2021521159A5 (enExample)
JP2003510369A (ja) フィブリン溶解剤の薬剤組成物
JP2023539476A5 (enExample)
CA2554018A1 (en) Lyophilization method to improve excipient crystallization
JP2025016453A5 (enExample)
CN105985942A (zh) 赖氨酰肽链内切酶冻干及贮存保护剂
CN114752703A (zh) 一种新型冠状病毒核酸的冻干型检测试剂及其制备方法
JP2023538669A5 (enExample)
US7101693B2 (en) Plasticized hydrophilic glasses for improved stabilization of biological agents
WO2019028976A1 (zh) 耐热保护剂、猪瘟可室温保存活疫苗及其制备方法和应用
JP2024521329A5 (enExample)
AU2022217094B2 (en) Botulinum toxin freeze-dried dosage form composition storable for long time
CN114317700A (zh) 荧光pcr试剂冻干保护剂、冻干方法及应用
CN116209460A (zh) 用于治疗或预防由冠状病毒引起的人或动物的病毒感染的菠萝蛋白酶、菠萝酶、木菠萝素类凝集素、来自菠萝植物茎和/或果的提取物、组合制剂、菠萝蛋白酶抑制剂、蛋白质-蛋白酶混合物和外源性非酶糖化产生的糖化菠萝酶蛋白
JP2022514942A (ja) ペグアスパラガーゼの凍結乾燥組成物
CN117368453A (zh) 心肌炎症复合质控品及其制备方法
EP4628092A8 (en) Insulin aspart composition (embodiments)
CN103301453A (zh) 一种猪繁殖与呼吸综合征冻干疫苗及其制备方法
CN117617230A (zh) 一种外泌体冻干制剂的制备方法